Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy
High PIV levels may serve as a predictor of long-term mortality in patients with HCM. PIV could be a useful screening tool for identifying HCM patients at increased risk of adverse outcomes.
Authors
- Mert İlker Hayıroğlu (ORCID: https://orcid.org/0000-0001-6515-7349)
- Tuğba Çetin (ORCID: https://orcid.org/0000-0001-6117-8329)
- Şeyda Dereli (ORCID: https://orcid.org/0009-0004-4881-369X)
- Levent Pay (ORCID: https://orcid.org/0000-0002-7491-8119)
- Tufan Çınar (ORCID: https://orcid.org/0000-0001-8188-5020)
- Ahmet Çağdaş Yumurtaş (ORCID: https://orcid.org/0000-0002-7311-2826)
- Hasan Kadı
Institutions
- Sivas State Hospital (TR)
- Haseki Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Medeniyet Medical Journal
- Published
- 2024-11-15
- DOI
- https://doi.org/10.4274/mmj.galenos.2024.96266
- Citations
- 1
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.40